ATE227135T1 - Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen - Google Patents
Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungenInfo
- Publication number
- ATE227135T1 ATE227135T1 AT00927713T AT00927713T ATE227135T1 AT E227135 T1 ATE227135 T1 AT E227135T1 AT 00927713 T AT00927713 T AT 00927713T AT 00927713 T AT00927713 T AT 00927713T AT E227135 T1 ATE227135 T1 AT E227135T1
- Authority
- AT
- Austria
- Prior art keywords
- actives
- hypertonic
- miotic
- ophthalmic compositions
- agents
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000003547 miosis Effects 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 208000002177 Cataract Diseases 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010047531 Visual acuity reduced Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 210000005252 bulbus oculi Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000544 cholinesterase inhibitor Substances 0.000 abstract 1
- 230000000718 cholinopositive effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 230000007850 degeneration Effects 0.000 abstract 1
- 230000004313 glare Effects 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 239000003604 miotic agent Substances 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 abstract 1
- 229960002673 sulfacetamide Drugs 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 230000004382 visual function Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999RM000259A IT1306135B1 (it) | 1999-04-26 | 1999-04-26 | Composizioni oftalmiche per il trattamento delle turbe visivecaratterizzate da ridotta sensibilita' al contrasto. |
| PCT/IT2000/000151 WO2000064425A2 (en) | 1999-04-26 | 2000-04-14 | Miotic agents and hypertonic agents containing ophthalmic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE227135T1 true ATE227135T1 (de) | 2002-11-15 |
Family
ID=11406726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00927713T ATE227135T1 (de) | 1999-04-26 | 2000-04-14 | Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1173207B1 (de) |
| AT (1) | ATE227135T1 (de) |
| AU (1) | AU4609900A (de) |
| CA (1) | CA2370895A1 (de) |
| DE (1) | DE60000736T2 (de) |
| IT (1) | IT1306135B1 (de) |
| WO (1) | WO2000064425A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6540990B2 (en) | 2000-09-22 | 2003-04-01 | Gerard M. Nolan | Physiological method of improving vision |
| WO2002049612A2 (en) * | 2000-12-20 | 2002-06-27 | Alcon, Inc. | Hypertonic ophthalmic irrigation solution adapted for use in lasik surgery |
| ITMI20010708A1 (it) * | 2001-04-03 | 2002-10-03 | Alessandro Randazzo | Trattamento farmacologico degli aloni notturni e delle immagini fantasma con parasimpaticomimetici diluiti aceclidina/pilocarpina dopo inter |
| US10507245B2 (en) * | 2012-07-19 | 2019-12-17 | Luis Felipe Vejarano Restrepo | Ophthalmic formulation and method for ameliorating presbyopia |
| KR20210005134A (ko) * | 2018-04-24 | 2021-01-13 | 알러간, 인코포레이티드 | 안구 증상의 치료를 위한 필로카르핀 염산염의 용도 |
| CA3178254A1 (en) * | 2020-05-18 | 2021-11-25 | Jack Martin LIPMAN | Low-dose carbachol compositions and methods for treatment of night vision disturbance |
| AU2021338618B2 (en) * | 2020-09-11 | 2024-02-01 | Intratus-Nevada, Inc. | Compositions and methods for treating presbyopia, hyperopia, astigmatism, decreased stereopsis, and decreased contrast sensitivity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60149521A (ja) * | 1984-01-18 | 1985-08-07 | Eisai Co Ltd | 高眼圧・緑内障治療・予防用点眼剤 |
-
1999
- 1999-04-26 IT IT1999RM000259A patent/IT1306135B1/it active
-
2000
- 2000-04-14 CA CA002370895A patent/CA2370895A1/en not_active Abandoned
- 2000-04-14 DE DE60000736T patent/DE60000736T2/de not_active Expired - Fee Related
- 2000-04-14 WO PCT/IT2000/000151 patent/WO2000064425A2/en not_active Ceased
- 2000-04-14 EP EP00927713A patent/EP1173207B1/de not_active Expired - Lifetime
- 2000-04-14 AU AU46099/00A patent/AU4609900A/en not_active Abandoned
- 2000-04-14 AT AT00927713T patent/ATE227135T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM990259A1 (it) | 2000-10-26 |
| DE60000736D1 (de) | 2002-12-12 |
| DE60000736T2 (de) | 2003-07-17 |
| IT1306135B1 (it) | 2001-05-30 |
| EP1173207A2 (de) | 2002-01-23 |
| WO2000064425A2 (en) | 2000-11-02 |
| AU4609900A (en) | 2000-11-10 |
| WO2000064425A3 (en) | 2001-04-12 |
| EP1173207B1 (de) | 2002-11-06 |
| CA2370895A1 (en) | 2000-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fish et al. | Management of ocular thermal and chemical injuries, including amniotic membrane therapy | |
| YU46899A (sh) | Kontrolisano oslobadjanje farmaceutika u prednjoj komori oka | |
| EA200501018A1 (ru) | Офтальмологический препарат для профилактики и лечения болезненных состояний глаз | |
| JP2005523928A5 (de) | ||
| TWI255714B (en) | Method for treating meibomian gland disease | |
| DE69917040D1 (de) | Augenlösung mit tetracyclin für behandlung von trockenen augen | |
| MX9805033A (es) | Uso de ciertos compuestos de isoquinolinosulfonilo para el tratamiento de glaucoma e isquemia ocular. | |
| RU2004134733A (ru) | Агенты, которые регулируют, ингибируют или модулируют активность и/или экспрессию факторов роста соединительной ткани (фрст), в качестве уникальных средств для снижения внутриглазного давления и лечения глаукоматозных ретинопатий/оптических невропатий | |
| CA2282757A1 (en) | Opthalmic composition | |
| EP1110554A4 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
| IT1305306B1 (it) | Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia. | |
| ATE227135T1 (de) | Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen | |
| AU4672300A (en) | Biochemical methods that eliminate corneal scars, opacification and haze | |
| RU2000129352A (ru) | Способ хирургического лечения открытоугольной глаукомы | |
| ATE326972T1 (de) | Heilende zusammensetzung für intraokulare hypertension oder glaukom | |
| RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
| WO2002080915A3 (en) | Composition for the treatment of night sight problems (halos, coma and glare) comprising aceclidine | |
| ATE251905T1 (de) | Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien | |
| DE69829062D1 (de) | Verwendung von flunarizin zur topischen behandlung ocularem hochdruck | |
| ATE257371T1 (de) | Augenspüllösung | |
| KR940019300A (ko) | 안내(眼內) 세정 및 적출 안구 보존제 | |
| ATE293969T1 (de) | Verwendung von hydroxyeicosatetraensäure für intraokuläre chirurgie | |
| Khan et al. | Bilateral congenital stromal cyst of the cornea | |
| RU97113443A (ru) | Способ лечения ожогов глаз | |
| Ritch | High intraocular pressure and survival: the Framingham studies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |